Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: A single-center, prospective, randomized study

Journal of Endovascular Therapy

Volumn 20, Issue 6, 2013, Pages 805-814

  Gandini, Roberto ^a   Del Giudice, Costantino ^a   Merolla, Stefano ^a   Morosetti, Daniele ^a   Pampana, Enrico ^a   Simonetti, Giovanni ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Angioplasty; Critical limb ischemia; Debulking; Drug coated balloon; Drug eluting balloon; Excimer laser; In stent restenosis; Laser atherectomy; Occlusion; Paclitaxel; Stenosis; Stent; Superficial femoral artery

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; LIDOCAINE; PACLITAXEL;

ADULT; AGED; ARTICLE; ATHERECTOMY; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DEATH; DISSECTION; DRUG ELUTING STENT; FEMALE; HEMATOMA; HUMAN; LEG AMPUTATION; LIMB ISCHEMIA; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROPERITONEAL HEMORRHAGE; REVASCULARIZATION; SUPERFICIAL FEMORAL ARTERY; SUPERFICIAL FEMORAL ARTERY STENT; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR PATENCY;

AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOPLASTY, BALLOON; ATHERECTOMY; CHRONIC DISEASE; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; CRITICAL ILLNESS; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LASERS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; RECURRENCE; RETREATMENT; RISK FACTORS; ROME; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY;

EID: 84890030715     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/13-4308MR.1     Document Type: Article

References (28)

1. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888.
2. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745-2749.
3. Krankenberg H, Schluter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116:285-292.
4. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261-269.
5. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
6. Soga Y, Iida O, Hirano K, et al. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. J Vasc Surg. 2011;54:1058-1066.
7. Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg. 2007;33:453-460.
8. Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358-1365.
9. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699.
10. Ansel GM, Lumsden AB. Evolving modalities for femoropopliteal interventions. J Endovasc Ther. 2009;16(Suppl II):II82-97.
11. Stabile E, Virga V, Salemme L, et al. Drugeluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol. 2012;60:1739-1742.
12. Manzi M, Cester G, Palena LM. Paclitaxel-coated balloon angioplasty for lower extremity revascularization: a new way to fight in-stent restenosis. J Cardiovasc Surg (Torino). 2010;51:567-571.
13. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol. 1992;18:433-440.
14. Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol. 2012;59:16-23.
15. Gray BH, Laird JR, Ansel GM et al. Complex endovascular treatment for critical limb ischemia in poor surgical candidates: a pilot study. J Endovasc Ther. 2002;9:599-604.
16. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517-538.
17. Soga Y, Iida O, Hirano K, et al. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg. 2010;52:608-615.
18. Dick P, Sabeti S, Mlekusch W, et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology. 2008;248:297-302.
19. Zeller T, Rastan A, Sixt S, et al. Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol. 2006;48:1573-1578.
20. Trentmann J, Charalambous N, Djawanscher M, et al. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. J Cardiovasc Surg (Torino). 2010;51:551-560.
21. Rittger H, Brachmann J, Sinha AM, et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drugeluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol. 2012;59:1377-1382.
22. Scheller B, Clever YP, Kelsch B, et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv. 2012;5:323-330.
23. Yeo KK, Malik U, Laird JR. Outcomes following treatment of femoropopliteal in-stent restenosis: a single center experience. Catheter Cardiovasc Interv. 2011;78:604-608.
24. Shafique S, Nachreiner RD, Murphy MP, et al. Recanalization of infrainguinal vessels: Silver-Hawk, laser, and the remote superficial femoral artery endarterectomy. Semin Vasc Surg. 2007;20:29-36.
25. Schillinger M, Exner M, Mlekusch W, et al. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. Radiology. 2002;224:529-535.
26. Inoue S, Koyama H, Miyata T, et al. Pathogenetic heterogeneity of in-stent lesion formation in human peripheral arterial disease. J Vasc Surg. 2002;35:672-678.
27. Laird JR, Yeo KK, Rocha-Singh K, et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE Study. Catheter Cardiovasc Interv. 2012;80:852-859.
28. van den Berg JC, Pedrotti M, Canevascini R, et al. Endovascular treatment of in-stent restenosis using excimer laser angioplasty and drug eluting balloons. J Cardiovasc Surg (Torino). 2012;53:215-222.